NM_000208.4:c.2682+2860C>A

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_000208.4(INSR):​c.2682+2860C>A variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.109 in 152,006 control chromosomes in the GnomAD database, including 1,535 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.11 ( 1535 hom., cov: 31)

Consequence

INSR
NM_000208.4 intron

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: -0.185

Publications

2 publications found
Variant links:
Genes affected
INSR (HGNC:6091): (insulin receptor) This gene encodes a member of the receptor tyrosine kinase family of proteins. The encoded preproprotein is proteolytically processed to generate alpha and beta subunits that form a heterotetrameric receptor. Binding of insulin or other ligands to this receptor activates the insulin signaling pathway, which regulates glucose uptake and release, as well as the synthesis and storage of carbohydrates, lipids and protein. Mutations in this gene underlie the inherited severe insulin resistance syndromes including type A insulin resistance syndrome, Donohue syndrome and Rabson-Mendenhall syndrome. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Oct 2015]
INSR Gene-Disease associations (from GenCC):
  • insulin-resistance syndrome type A
    Inheritance: AD, AR Classification: DEFINITIVE, STRONG, SUPPORTIVE, LIMITED Submitted by: Labcorp Genetics (formerly Invitae), Orphanet, Genomics England PanelApp, G2P
  • Donohue syndrome
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Orphanet, Labcorp Genetics (formerly Invitae), Genomics England PanelApp, G2P
  • hyperinsulinism due to INSR deficiency
    Inheritance: AD Classification: STRONG, MODERATE, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), Orphanet, Genomics England PanelApp, Ambry Genetics
  • Rabson-Mendenhall syndrome
    Inheritance: AR Classification: STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), Orphanet, Genomics England PanelApp

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.91).
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.478 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_000208.4. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
INSR
NM_000208.4
MANE Select
c.2682+2860C>A
intron
N/ANP_000199.2
INSR
NM_001079817.3
c.2646+2860C>A
intron
N/ANP_001073285.1

Ensembl Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
INSR
ENST00000302850.10
TSL:1 MANE Select
c.2682+2860C>A
intron
N/AENSP00000303830.4
INSR
ENST00000341500.9
TSL:1
c.2646+2860C>A
intron
N/AENSP00000342838.4

Frequencies

GnomAD3 genomes
AF:
0.109
AC:
16561
AN:
151886
Hom.:
1529
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.138
Gnomad AMI
AF:
0.167
Gnomad AMR
AF:
0.204
Gnomad ASJ
AF:
0.0873
Gnomad EAS
AF:
0.493
Gnomad SAS
AF:
0.0903
Gnomad FIN
AF:
0.0848
Gnomad MID
AF:
0.0987
Gnomad NFE
AF:
0.0469
Gnomad OTH
AF:
0.101
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.109
AC:
16591
AN:
152006
Hom.:
1535
Cov.:
31
AF XY:
0.116
AC XY:
8622
AN XY:
74286
show subpopulations
African (AFR)
AF:
0.138
AC:
5711
AN:
41444
American (AMR)
AF:
0.205
AC:
3129
AN:
15262
Ashkenazi Jewish (ASJ)
AF:
0.0873
AC:
303
AN:
3472
East Asian (EAS)
AF:
0.494
AC:
2541
AN:
5148
South Asian (SAS)
AF:
0.0900
AC:
434
AN:
4822
European-Finnish (FIN)
AF:
0.0848
AC:
896
AN:
10564
Middle Eastern (MID)
AF:
0.0890
AC:
26
AN:
292
European-Non Finnish (NFE)
AF:
0.0469
AC:
3188
AN:
67990
Other (OTH)
AF:
0.100
AC:
211
AN:
2104
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.504
Heterozygous variant carriers
0
697
1394
2091
2788
3485
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
186
372
558
744
930
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0742
Hom.:
1974
Bravo
AF:
0.123
Asia WGS
AF:
0.252
AC:
875
AN:
3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.91
CADD
Benign
0.92
DANN
Benign
0.62
PhyloP100
-0.18
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs8110533; hg19: chr19-7138828; API